# Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia

> **NCT01423747** · PHASE3 · UNKNOWN · sponsor: **St. Anna Kinderkrebsforschung** · enrollment: 400 (estimated)

## Conditions studied

- Lymphoblastic Leukemia, Acute, Childhood;

## Interventions

- **DRUG:** VP16
- **RADIATION:** TBI
- **DRUG:** VP16, ATG
- **RADIATION:** TBI
- **DRUG:** Fludarabine, OKT3, Treosulfan, Thiotepa
- **DRUG:** VP16, ATG
- **RADIATION:** TBI

## Key facts

- **NCT ID:** NCT01423747
- **Lead sponsor:** St. Anna Kinderkrebsforschung
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2003-07
- **Primary completion:** 2011-09
- **Final completion:** 2016-09
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2015-06-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01423747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01423747, "Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01423747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*